These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 20854047

  • 1. Onset of effect of aclidinium, a novel, long-acting muscarinic antagonist, in patients with COPD.
    Vestbo J, Vogelmeier C, Creemers J, Falques M, Ribera A, Gil EG.
    COPD; 2010 Oct; 7(5):331-6. PubMed ID: 20854047
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of aclidinium bromide 400 μg twice daily compared with placebo and tiotropium in patients with moderate to severe COPD.
    Fuhr R, Magnussen H, Sarem K, Llovera AR, Kirsten AM, Falqués M, Caracta CF, Garcia Gil E.
    Chest; 2012 Mar; 141(3):745-752. PubMed ID: 21903737
    [Abstract] [Full Text] [Related]

  • 3. Bronchodilatory effects of aclidinium bromide, a long-acting muscarinic antagonist, in COPD patients.
    Joos GF, Schelfhout VJ, Pauwels RA, Kanniess F, Magnussen H, Lamarca R, Jansat JM, Garcia Gil E.
    Respir Med; 2010 Jun; 104(6):865-72. PubMed ID: 20044242
    [Abstract] [Full Text] [Related]

  • 4. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
    Brashier B, Dhembare P, Jantikar A, Mahadik P, Gokhale P, Gogtay JA, Salvi SS.
    Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
    [Abstract] [Full Text] [Related]

  • 5. Bronchodilatory effects of NVA237, a once daily long-acting muscarinic antagonist, in COPD patients.
    Fogarty C, Hattersley H, Di Scala L, Drollmann A.
    Respir Med; 2011 Mar; 105(3):337-42. PubMed ID: 21144724
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of a 12-week treatment with twice-daily aclidinium bromide in COPD patients (ACCORD COPD I).
    Kerwin EM, D'Urzo AD, Gelb AF, Lakkis H, Garcia Gil E, Caracta CF, ACCORD I study investigators.
    COPD; 2012 Apr; 9(2):90-101. PubMed ID: 22320148
    [Abstract] [Full Text] [Related]

  • 7. A 4-year trial of tiotropium in chronic obstructive pulmonary disease.
    Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M, UPLIFT Study Investigators.
    N Engl J Med; 2008 Oct 09; 359(15):1543-54. PubMed ID: 18836213
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of twice-daily aclidinium bromide in COPD patients: the ATTAIN study.
    Jones PW, Singh D, Bateman ED, Agusti A, Lamarca R, de Miquel G, Segarra R, Caracta C, Garcia Gil E.
    Eur Respir J; 2012 Oct 09; 40(4):830-6. PubMed ID: 22441743
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological assessment of the onset of action of aclidinium and glycopyrronium versus tiotropium in COPD patients and human isolated bronchi.
    Rogliani P, Calzetta L, Ora J, Lipsi R, Segreti A, Matera MG, Cazzola M.
    Eur J Pharmacol; 2015 Aug 15; 761():383-90. PubMed ID: 25952728
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Comparison of tiotropium inhalation capsules and ipratropium metered dose inhaler in a randomized, double-blind, double-dummy, efficacy and safety study in patients with chronic obstructive pulmonary disease].
    Zheng JP, Kang J, Cai BQ, Zhou X, Cao ZL, Bai CX, Zhong NS.
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jun 15; 29(6):363-7. PubMed ID: 17045014
    [Abstract] [Full Text] [Related]

  • 13. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group.
    Maesen FP, Smeets JJ, Sledsens TJ, Wald FD, Cornelissen PJ.
    Eur Respir J; 1995 Sep 15; 8(9):1506-13. PubMed ID: 8575576
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium.
    Donohue JF, Fogarty C, Lötvall J, Mahler DA, Worth H, Yorgancioglu A, Iqbal A, Swales J, Owen R, Higgins M, Kramer B, INHANCE Study Investigators.
    Am J Respir Crit Care Med; 2010 Jul 15; 182(2):155-62. PubMed ID: 20463178
    [Abstract] [Full Text] [Related]

  • 16. A randomized study of tiotropium Respimat Soft Mist inhaler vs. ipratropium pMDI in COPD.
    Voshaar T, Lapidus R, Maleki-Yazdi R, Timmer W, Rubin E, Lowe L, Bateman E.
    Respir Med; 2008 Jan 15; 102(1):32-41. PubMed ID: 17996436
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Preoperative use of inhaled tiotropium in lung cancer patients with untreated COPD.
    Kobayashi S, Suzuki S, Niikawa H, Sugawara T, Yanai M.
    Respirology; 2009 Jul 15; 14(5):675-9. PubMed ID: 19476597
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.